SYTL4 and cancer: Mutation-driven regulation of <i>SYTL4</i> expression, treatment response to trastuzumab, cancer hallmark enrichment, and survival associations were evaluated using established bioinformatic tools and enrichment analysis based on integrated cancer hallmark gene sets.